EC 1.1.1.188 - (5 Z ,13 E ) - (15 S ) - 9α,11α,15- trihydroxyprosta- 5,13- dienoate:NADP ⁺ 11- oxidoreductase (prostaglandin- F synthase)

3D structures of EC 1.1.1.188 - prostaglandin-F synthase in Protein Data Bank

updated: 6 January 2022, 2:15

1. 1ry0: Structure of Prostaglandin F Synthase with Prostaglandin D2
2. 1ry8: Prostaglandin F Synthase Complexed with Nadph and Rutin
3. 1vbj: The Crystal Structure of Prostaglandin F Synthase from Trypanosoma Brucei
4. 1xf0: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) Complexed with Delta4- Androstene-3,17-dione and Nadp
5. 1zq5: Crystal Structure of Human Androgenic 17beta-hydroxysteroid Dehydrogenase Type 5 in Complexed with a Potent Inhibitor Em1404
6. 6a7b: AKR1C3 Complexed with New Inhibitor with Novel Scaffold
7. 2f38: Crystal Structure of Prostaglandin F Synathase Containing Bimatoprost
8. 2fgb: Crystal Structure of Human 17bet A-hydroxysteroid Dehydrogenase Type 5 in Complexes with Peg and Nadp
9. 3r43: AKR1C3 Complexed with Mefenamic Acid
10. 3r58: AKR1C3 Complex with Naproxen
11. 4dbs: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 3-[4 -(nitronaphthalen-1-amino)) Benzoic Acid
12. 4dbu: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 3-((4 -(trifluoromethyl)phenyl) Amino)benzoic Acid
13. 3uwe: AKR1C3 Complexed with 3-phenoxybenzoic Acid
14. 3r6i: AKR1C3 Complex with Meclofenamic Acid
15. 3r7m: AKR1C3 Complex with Sulindac
16. 3r8g: AKR1C3 Complex with Ibuprofen
17. 3r8h: AKR1C3 Complex with Zomepirac
18. 3r94: AKR1C3 Complex with Flurbiprofen
19. 4f40: X-ray Crystal Structure of Apo Prostaglandin F Synthase from Leishmania Major Friedlin
20. 4fzi: Crystal Structure of Prostaglandin F Synthase from Trypanosoma Cruzi
21. 3ufy: AKR1C3 Complex with R-naproxen
22. 3ug8: AKR1C3 Complex with Indomethacin at Ph 7.5
23. 3ugr: AKR1C3 Complex with Indomethacin at Ph 6.8
24. 4g5d: X-ray Crystal Structure of Prostaglandin F Synthase from Leishmania Major Friedlin Bound to Nadph
25. 4gie: Crystal Structure of Prostaglandin F Synthase from Trypanosoma Cruzi Bound to Nadp
26. 4fa3: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with (r)-1-(naphthalen-2-ylsulfonyl)piperidine-3- Carboxylic Acid (86)
27. 4fal: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)-n- Methylbenzamide (80)
28. 4fam: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)benzoic Acid (17)
29. 4dbw: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 (AKR1C3) in Complex with Nadp+ and 2'-desmethyl-indomethacin
30. 4dz5: W227F Active Site Mutant of AKR1C3
31. 6gxk: Crystal Structure of Aldo-keto Reductase 1c3 (AKR1C3) Complexed with Inhibitor.
32. 4h7c: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with 1-{4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl}-2- Pyrrolidinone
33. 6f78: Potent and Selective Aldo-keto Reductase 1c3 (AKR1C3) Inhibitors Based on The Benzoisoxazole Moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
34. 6f2u: Potent and Selective Aldo-keto Reductase 1c3 (AKR1C3) Inhibitors Based on The Benzoisoxazole Moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
35. 4hmn: Crystal Structure of Human 17beta-hydroxysteroid Dehydrogenase Type 5 in Complex with (4-(4-chlorophenyl)piperazin-1-yl)(morpholino) Methanone (24)
36. 4wrh: AKR1C3 Complexed with Breakdown Product of N-(tert-butyl)-2-(2-chloro- 4-(((3-mercapto-5-methyl-4h-1,2,4-triazol-4-yl)amino)methyl)-6- Methoxyphenoxy)acetamide
37. 5hnu: Crystal Structure of AKR1C3 Complexed with Octyl Gallate
38. 5hnt: Crystal Structure of AKR1C3 Complexed with Cape
39. 4zfc: Crystal Structure of AKR1C3 Complexed with Glicazide
40. 4yvx: Crystal Structure of AKR1C3 Complexed with Glimepiride
41. 4yvv: Crystal Structure of AKR1C3 Complexed with Glibenclamide